GlassScriptPhysician profile
Vinay A Shah
NPI 1013951409
$94,695.00
in general payments reported to CMS, 2019-2025
24 companies · $17K in 2025
The $17K reported for 2025 was more than what 94% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $913 · 2021: $35K · 2022: $12K · 2023: $12K · 2024: $17K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Consulting Fee: $16K · Food and Beverage: $2,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,333.34 |
| Consulting Fee | $16,333.33 |
| Food and Beverage | $2,063.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $40,000.01 | 2022-2024 | Xipere |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35,023.51 | 2021 | |
| Glaukos Corporation | $16,333.33 | 2025 | Istent Infinite, Travoprost Intraocular Implant - Idose |
| Carl Zeiss Meditec, INC. | $750.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $366.60 | 2022-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $306.05 | 2023-2025 | Clareon, Constellation, Ngenuity |
| Apellis Pharmaceuticals, INC. | $301.05 | 2024-2025 | Syfovre |
| Genentech USA, INC. | $215.93 | 2019-2025 | Vabysmo |
| Dutch Ophthalmic, USA | $170.70 | 2024 | Tissueblue, Eva, Combined Machine |
| Astellas Pharma US INC | $162.15 | 2024-2025 | Izervay |
| Ani Pharmaceuticals, INC. | $161.98 | 2024-2025 | Yutiq, Purified Cortrophin Gel, Iluvien |
| Abbvie INC. | $146.90 | 2022-2025 | Ozurdex |
| Onmark, INC. | $137.49 | 2025 | |
| Novartis Pharmaceuticals Corporation | $109.69 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $80.98 | 2023 | Xeomin |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $65.97 | 2020-2021 | |
| Genentech, INC. | $65.31 | 2021-2023 | Susvimo, Vabysmo |
| Glaxosmithkline, LLC. | $61.22 | 2020-2022 | |
| Sandoz INC. | $53.47 | 2024 | Cimerli |
| Johnson & Johnson Surgical Vision, INC. | $52.50 | 2019 | |
| Biogen, INC. | $48.23 | 2024 | Byooviz |
| Ocular Therapeutix, INC. | $46.00 | 2025 | Dextenza |
| Alimera Sciences, INC. | $19.22 | 2021 | |
| Kala Pharmaceuticals, INC. | $16.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.